For pharmaceutical brands, packaging has a responsibility that goes far beyond putting a product inside a box. A medicine carton needs to protect the product, accommodate important information, support clear identification and perform reliably throughout storage, handling and distribution.
For UK pharmaceutical businesses, choosing the right tuck end boxes for medicines therefore requires more thought than selecting a standard retail carton. The box needs to work with the primary packaging, the approved artwork and the way the medicine will be handled before it reaches the patient.
This is where custom pharmaceutical packaging can provide a practical solution. A carton can be developed around the dimensions of the medicine, the required information and the intended packaging process rather than forcing the product into a standard-sized box.
The most important principle is simple: pharmaceutical packaging should be designed around the product and its requirements, not just around appearance.
Why Pharmaceutical Packaging Requires a Different Approach
A pharmaceutical carton can carry information that is essential to identifying and using a medicine correctly. Depending on the product, the packaging may need to accommodate the medicine name, strength, pharmaceutical form, warnings, batch and expiry information, barcode, manufacturer details and other required information.
The MHRA explains that packaging and labelling for medicines sold in the UK must provide clear information that allows patients and healthcare professionals to identify medicines. Its current guidance was updated in July 2026.
This creates a common pain point for pharmaceutical brands: there is often a lot of information that needs to fit onto a relatively small carton without making the design difficult to read.
A solution is to consider the packaging structure and artwork together from the beginning. The available panels, folds and closure areas should be understood before the final artwork is prepared. This allows the brand and packaging supplier to create a carton that provides enough usable space without unnecessarily increasing the box size.
What Are Tuck End Boxes for Medicines?
Tuck end boxes are folding cartons that use tuck-in flaps to close the box. They are widely used across retail packaging, including cosmetics, healthcare products, supplements and pharmaceutical cartons. Current UK packaging suppliers commonly offer both straight tuck and reverse tuck structures for these applications.
The two common structures are straight tuck end (STE) and reverse tuck end (RTE).
With a straight tuck end box, the top and bottom flaps generally tuck in the same direction. A reverse tuck end box uses opposing flap directions. The difference may appear small, but the structure can affect how the carton is assembled, opened and closed.
For pharmaceutical applications, the right structure should be selected according to the product dimensions, filling process, handling requirements and desired closure—not simply because one style is more popular.
Start With the Medicine, Not the Box
One of the biggest mistakes when developing medicine packaging boxes is choosing a box style first and trying to make the product fit afterwards.
Instead, start with the complete package that needs to go inside the carton.
A medicine may be supplied in a blister pack, bottle, tube, sachet or another primary container. Some products may also need to be packed with a patient information leaflet.
The outer carton therefore needs enough internal space for the complete configuration.
For example, a bottle that sits loosely inside an oversized carton may move during transportation. A carton that is too tight could make assembly difficult or create unnecessary pressure on the primary packaging. A box designed without considering the leaflet may also become difficult to close properly.
The solution is custom sizing.
By developing the carton around the actual product dimensions, pharmaceutical brands can achieve a more controlled fit while avoiding unnecessary empty space.
This is one of the main advantages of custom tuck end boxes over generic stock cartons.
Choosing Between Straight and Reverse Tuck End Boxes
There is no universal rule that says every pharmaceutical product should use one particular tuck structure.
Straight tuck end boxes can be useful where the production or assembly process benefits from the flap arrangement. Reverse tuck end boxes are also widely used for pharmaceutical and healthcare products, including tablet cartons and other medicine packaging. UK suppliers currently market reverse tuck cartons specifically for pharmaceutical, vitamin and health-supplement applications.
The decision should therefore consider how the box will actually be used.
If thousands of cartons are being packed on a production line, the closure structure may need to work efficiently with the filling process. If the carton will be repeatedly opened and closed by the consumer, the closure experience becomes more important.
This is why an experienced packaging supplier should look at the product, packing workflow and end-use requirements together rather than recommending a structure in isolation.
Make Information Clear Without Losing Brand Identity
Pharmaceutical packaging has to balance two different priorities: brand recognition and information clarity.
A pharmaceutical company may want its cartons to have distinctive colours, typography and graphics, but the packaging still needs to make important information easy to locate and read.
This is particularly important because packaging is part of the medicine-use experience, not simply a marketing surface.
The MHRA’s best-practice guidance specifically considers readability, information design and the reduction of medication errors when discussing medicines packaging.
A good pharmaceutical packaging box should therefore use design to create a clear information hierarchy. The brand can remain visually recognisable while product name, strength and other important information remain prominent.
This approach also makes it easier for a pharmaceutical brand to create a consistent packaging system across different products.
For example, the same overall design language can be used across several medicines while different colours or layouts help distinguish product variants.
Allow Space for Braille and Other Required Information
Accessibility should be considered before the packaging artwork is finalised.
For UK medicines, applicable requirements include Braille on medicine labelling. The MHRA’s guidance states that the name of the medicine must be displayed in Braille on the labelling.
This means the packaging design needs to account for Braille placement alongside the printed artwork.
Trying to add such requirements at the end of the design process can create problems with available panel space, visual hierarchy and production. Building them into the dieline from the beginning provides a much more controlled approach.
Pharmaceutical brands should also ensure that the final packaging artwork has been reviewed and approved through the appropriate regulatory process. A packaging manufacturer can produce the carton to an approved specification, but it should not be assumed that the box supplier determines whether the medicine packaging itself is legally compliant.
Protect the Product Throughout the Supply Chain
The carton needs to perform beyond the production facility.
A medicine can pass through manufacturing, warehousing, distribution, pharmacies and other handling environments before reaching the end user. During this journey, the packaging can experience compression, vibration and repeated handling.
This makes material and structural specification important.
For a lightweight tablet pack, a folding carton may provide an appropriate balance between protection, printability and cost. A product with a bottle or multiple components may require a different internal configuration.
The important question is not simply, “Which board is strongest?”
It is:
“What level of protection does this specific product and distribution environment require?”
That distinction leads to better packaging decisions and avoids unnecessarily over-engineering a carton.
Consider the Patient Information Leaflet
Another consideration for pharmaceutical cartons is the relationship between the outer packaging and the patient information leaflet.
The MHRA states that medicines must include a patient information leaflet where the label does not contain all the necessary information. The leaflet also needs to meet requirements around accessibility and readability.
This means the outer carton may need to accommodate the leaflet alongside the primary medicine packaging.
A common practical problem is designing the carton around the medicine alone and only later discovering that the leaflet changes the required internal dimensions.
The better approach is to consider the complete packaging configuration at the sampling stage. Place the actual primary packaging and leaflet inside the proposed carton and check the fit before production.
Custom Printed Pharmaceutical Boxes Support Consistent Branding
Pharmaceutical packaging doesn’t need to look generic.
Custom printed pharmaceutical boxes allow brands to develop consistent visual systems across product ranges while maintaining the information required for each individual medicine.
High-quality printing can be used for brand colours, product identification, typography and supporting graphics. Depending on the project, finishes such as matt or gloss coatings can also be considered.
However, premium finishes should always serve a purpose. Pharmaceutical packaging is primarily about clarity, identification and usability. Decorative elements should not compete with important information.
For this reason, a clean and structured design can often be more effective than an overly decorative carton.
Why Physical Sampling Matters
A pharmaceutical carton can look correct on a computer screen and still present problems when physically produced.
A sample allows the packaging team to check the actual product fit, folding, closure and information placement before committing to a larger production run.
It also provides an opportunity to see how the printed colours and finishing appear on the selected board.
For pharmaceutical brands, this stage can prevent expensive mistakes. A small dimensional problem discovered after mass production can be considerably more costly than identifying it during prototyping.
At Artsy Packaging, custom packaging projects can be developed around specific product dimensions, materials, printing requirements and structural specifications. The company also provides custom medical and pharmaceutical packaging solutions designed around different product requirements.
How Artsy Packaging Can Help With Pharmaceutical Boxes
At Artsy Packaging, the approach should begin with understanding what the pharmaceutical brand actually needs rather than simply selecting a box from a standard catalogue.
The process can be structured around the product, dimensions, packaging format, artwork and production requirements.
For example:
Product → measurements → box structure → material → artwork → proof → sample → production
This approach helps address the main pain points pharmaceutical brands face: incorrect sizing, insufficient printable space, poor product fit and packaging that has not been physically assessed before production.
Artsy’s custom packaging capabilities also allow brands to consider different box structures, printing options, materials and finishes according to the project.
For pharmaceutical businesses, this means the packaging can be developed as a complete system rather than treating the carton as an afterthought.
UK Pharmaceutical Packaging and Regulatory Considerations
Pharmaceutical brands should always separate packaging manufacturing from regulatory approval.
The MHRA approves packaging and labelling information for medicines sold in the UK, and its guidance explains the information that must be provided to consumers and healthcare professionals.
There have also been important UK-specific packaging changes. For example, since 1 January 2025, medicines within the scope of the relevant arrangements must use a UK-specific outer carton labelled “UK Only”, as explained in current MHRA guidance.
The MHRA also provides guidance on submitting changes to labels and patient information leaflets, including the process for self-certification of certain changes.
Therefore, pharmaceutical brands should have the appropriate regulatory team review and approve the artwork before production. The packaging supplier’s role is then to manufacture the approved specification accurately.
This distinction is important because it prevents misleading claims that a particular box structure is automatically “MHRA compliant.”
Key Considerations
Choosing the right tuck end boxes for medicines is ultimately about finding the right balance between structure, protection, information and usability.
A pharmaceutical carton needs to fit the actual medicine and primary packaging, provide sufficient space for required information, support accessibility and withstand the practical demands of storage and distribution.
For UK pharmaceutical brands, the best approach is to treat packaging as part of the overall product system rather than simply as an outer box.
Whether a product requires a straight tuck end, reverse tuck end or another carton structure, the decision should be based on the medicine, packing process and approved packaging requirements.
With the right design and manufacturing process, custom pharmaceutical boxes can provide a professional, practical and consistent solution while keeping the needs of the product and end user at the centre of the packaging strategy.
